The Discounted Cash Flow (DCF) valuation of Armata Pharmaceuticals Inc (ARMP) is (50.91) USD. With the latest stock price at 1.40 USD, the upside of Armata Pharmaceuticals Inc based on DCF is -3736.4%.
Based on the latest price of 1.40 USD and our DCF valuation, Armata Pharmaceuticals Inc (ARMP) is a sell. selling ARMP stocks now will result in a potential gain of 3736.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 7.4% | 6.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (127.36) - (33.28) | (50.91) |
| Upside | -9197.0% - -2477.3% | -3736.4% |